EFFICACY OF ROSUVASTATIN VERSUS ATORVASTATIN IN PATIENTS WITH DIABETES: RESULTS OF A SUBGROUP ANALYSIS FROM THE POLARIS STUDY

被引：0
|
作者：
Leiter, L. A. [1 ]
Sosef, F. [2 ]
Ycas, J. [3 ]
Melezinkova, H. [4 ]
机构：
[1] Univ Toronto, St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada
[2] AstraZeneca, Molndal, Sweden
[3] AstraZeneca, Wilmington, DE USA
[4] AstraZeneca, Macclesfield, Cheshire, England
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70816-X
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [31] A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia
    Adsule, Samir Maruti
    Baig, Mirza Shiraz
    Gade, P. R.
    Khandelwal, P. N.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2009, 29 (02) : 74 - 79
  • [32] Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)
    Nicholls, Stephen J.
    Brandrup-Wognsen, Gunnar
    Palmer, Mike
    Barter, Philip J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (01): : 69 - 76
  • [33] The efficacy and safety of atorvastatin versus simvastatin in patients with and without type 2 diabetes
    Insull, W
    Kafonek, S
    Daley, WL
    Goldner, DB
    Zieve, F
    DIABETOLOGIA, 2000, 43 : A288 - A288
  • [34] Effects of rosuvastatin and atorvastatin on plasma lipids in Type 2 diabetes patients in the MERCURY I study
    Schuster, H
    Barter, PJ
    Stender, S
    Cheung, RC
    Bonnet, J
    Morrell, JM
    Watkins, C
    Kallend, D
    DIABETOLOGIA, 2004, 47 : A409 - A409
  • [35] Evaluation of Dose Efficacy of Treatment with Atorvastatin, Rosuvastatin And Simvastatin in Patients with Hyperlipidemia
    Demir, Orhan
    Sevimli, Serdar
    Degirmenci, Husnu
    Duman, Hakan
    Bakirci, Eftal Murat
    Demirelli, Selami
    Hamur, Hikmet
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C182 - C182
  • [36] Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study
    Hide, Michihiro
    Igarashi, Atsuyuki
    Yagami, Akiko
    Chinuki, Yuko
    Inomata, Naoko
    Fukunaga, Atsushi
    Kaiser, Guenther
    Wang, Junyi
    Matsushima, Soichiro
    Greenberg, Steven
    Khalil, Sam
    ALLERGOLOGY INTERNATIONAL, 2018, 67 (02) : 243 - 252
  • [37] Comparative Efficacy of Ezetimibe/Simvastatin, Rosuvastatin, and Atorvastatin in Uncontrolled Hyperlipidemia Patients
    Furman, Amy
    Meier, Joy L.
    Malmstrom, Robert A.
    Lopez, Julio R.
    Schaefer, Saul
    AMERICAN JOURNAL OF MANAGED CARE, 2011, 17 (08): : 538 - 544
  • [38] The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia
    Demir, Vahit
    Dogru, Mehmet Tolga
    Ede, Huseyin
    Yilmaz, Samet
    Alp, Caglar
    Celik, Yunus
    Yidirim, Nesligul
    CARDIOVASCULAR JOURNAL OF AFRICA, 2018, 29 (03) : 162 - 166
  • [39] Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial
    Ferdinand, KC
    Clark, LT
    Watson, KE
    Neal, RC
    Brown, CD
    Kong, BW
    Barnes, BO
    Cox, WR
    Zieve, FJ
    Isaacsohn, J
    Ycas, J
    Sager, PT
    Gold, A
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (02): : 229 - 235
  • [40] Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
    Colhoun, Helen M.
    Betteridge, D. John
    Durrington, Paul N.
    Hitman, Graham A.
    Neil, H. Andrew W.
    Livingstone, Shona J.
    Charlton-Menys, Valentine
    DeMicco, David A.
    Fuller, John H.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (05) : 810 - 819
12345